REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,334,371 | -26.3% | 4,578,280 | 0.0% | 0.45% | -26.7% |
| Q2 2023 | $106,307,662 | +31.5% | 4,578,280 | 0.0% | 0.62% | +39.8% |
| Q1 2023 | $80,852,425 | -35.1% | 4,578,280 | 0.0% | 0.44% | -41.2% |
| Q4 2022 | $124,529,216 | +85.2% | 4,578,280 | +17.6% | 0.75% | +70.0% |
| Q3 2022 | $67,247,000 | +7.1% | 3,893,843 | +8.4% | 0.44% | +23.6% |
| Q2 2022 | $62,772,000 | +129.4% | 3,591,081 | +122.8% | 0.36% | +126.8% |
| Q1 2022 | $27,367,000 | +70.2% | 1,611,703 | +171.6% | 0.16% | +101.3% |
| Q4 2021 | $16,081,000 | +253.4% | 593,395 | +286.5% | 0.08% | +290.0% |
| Q3 2021 | $4,550,000 | -22.9% | 153,512 | 0.0% | 0.02% | -23.1% |
| Q2 2021 | $5,898,000 | +25.9% | 153,512 | 0.0% | 0.03% | +30.0% |
| Q1 2021 | $4,684,000 | -20.0% | 153,512 | 0.0% | 0.02% | -9.1% |
| Q4 2020 | $5,856,000 | +23.1% | 153,512 | -25.7% | 0.02% | +15.8% |
| Q3 2020 | $4,756,000 | +3615.6% | 206,586 | +3918.4% | 0.02% | +1800.0% |
| Q2 2020 | $128,000 | – | 5,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |